Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Receivables - Other (2022 - 2025)

Historic Receivables - Other for Verrica Pharmaceuticals (VRCA) over the last 4 years, with Q1 2025 value amounting to $46000.0.

  • Verrica Pharmaceuticals' Receivables - Other fell 9222.97% to $46000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $46000.0, marking a year-over-year decrease of 9222.97%. This contributed to the annual value of $29000.0 for FY2024, which is 8273.81% down from last year.
  • According to the latest figures from Q1 2025, Verrica Pharmaceuticals' Receivables - Other is $46000.0, which was down 9222.97% from $29000.0 recorded in Q4 2024.
  • In the past 5 years, Verrica Pharmaceuticals' Receivables - Other registered a high of $592000.0 during Q1 2024, and its lowest value of $29000.0 during Q4 2024.
  • For the 4-year period, Verrica Pharmaceuticals' Receivables - Other averaged around $201769.2, with its median value being $168000.0 (2023).
  • In the last 5 years, Verrica Pharmaceuticals' Receivables - Other skyrocketed by 95714.29% in 2024 and then crashed by 9222.97% in 2025.
  • Quarter analysis of 4 years shows Verrica Pharmaceuticals' Receivables - Other stood at $99000.0 in 2022, then soared by 69.7% to $168000.0 in 2023, then plummeted by 82.74% to $29000.0 in 2024, then surged by 58.62% to $46000.0 in 2025.
  • Its Receivables - Other was $46000.0 in Q1 2025, compared to $29000.0 in Q4 2024 and $84000.0 in Q3 2024.